Summary_of_Changes_From_Prior_Solicitation.pdf

Notice: Summary of Changes 15-223-SOL-00185

The current solicitation # 15-223-SOL-00185 is a re-solicitation of the previously posted solicitation # 15-223-SOL-00106. The two solicitations are very similar, and this document summarizes the differences.

All documents in solicitation 15-223-SOL-00185 are based on the comparable document in 15-223-SOL- 00106. Where text previously found in solicitation # 15-223-SOL-00106 has been deleted from the current solicitation 15-223-SOL-00185, the text is formatted with double-strike-through and grey highlight: example. Where text that was not present in the previous solicitation # 15-223-SOL-00106 has been added in the current solicitation 15-223-SOL-00185, the text is formatted with yellow highlight:

example.

Summary of Changes from 15-223-SOL-00106 to 15-223-SOL-00185

SF 1449 Continuation

• Invoicing Instructions updated

• FAR Clause 52.212-5 updated o 52.222-54, Employment Eligibility Verification deselected

• FAR 52.227-14 Rights in Data, references to ALT II, IV and V deleted

• HHSAR Clauses and Provisions, hypertext link updated

• Attachment 9 Labor Categories and Descriptions added

• FAR 52.204-7 System for Award Management, alternate 1 added and full-text deleted

• DUNS number text deleted (non-applicable when FAR 52.204-7 is included)

Attachment 1, IDIQ SOW

• Title changed

• Compatibility with FDA Environment, Section 3.5, clarified in response to questions

• Incorrect reference to ‘Appendix B’ deleted

• Technical Environment, Section 3.7, clarified in response to questions

• ELN Mandatory Requirements, ‘Support PIV & digital signatures’ deleted

• ELN Mandatory Requirements, ‘diagnostic’ corrected to ‘agnostic’

• ELN Non-Mandatory Requirements, formatting corrected

Attachment 2, Task Order (Pilot) SOW

• Uses Cases made a separate section of the SOW

• Installation, Section 4.2 completely changed in response to questions. Installation now specifies it will take place prior to the 1-month period, vendors will assist FDA in installation, and the software will be hosted at the FDA.

• Configuration, Section 4.3, changed in response to questions. Configuration now specifies it will also take place prior to the 1-month period, and notes the configuration may have to take place on-site.

• Use Case 3, “Demonstrate or discuss whether this can be done using PIV cards.” deleted

• Reference to Section 5.4 of IDIQ SOW removed

• Government-Furnished Information and Equipment – added that the Government will provide access to, among other things, the FDA VPN, as appropriate

Attachment 3 ELN Pricing Worksheet – no change

Attachment 4 Past Performance Questionnaire

• Due date updated

• d.) Key Personnel and Staffing deleted

Attachment 5 Nondisclosure agreements – no change

Attachment 6 Technical Appendices – no change

Attachment 7 – Award Term Performance Evaluation and Measurement Plan

• Evaluation ratings reduced from four to three, ‘highly satisfactory’ deleted

• Use Case 3, “Demonstrate or discuss whether this can be done using PIV cards.” deleted

Attachment 8 Instructions to Offerors and Evaluation

• Basis of Award clarified per FAR Part 15 requirements to indicate that the Government may award without discussions or make a competitive range.

• Submission Instructions changed to refer to the SF 1449

• Offerors are encouraged to offer discounts on Task Order 1.

• “Minimal effort need to configure ELN solution for use cases” added to Factor 2 – Meets Job Requirements